News

Net profit of Venus Remedies rose 139.27% to Rs 22.97 crore in the quarter ended June 2026 as against Rs 9.60 crore during the previous quarter ended June 2025. Sales rose 30.38% to Rs 178.86 crore in the quarter ended June 2026 as against Rs 137.18 crore during the previous quarter ended June 2025. ParticularsQuarter EndedJun. 2026Jun. 2025% Var. Sales178.86137.18 30 OPM %19.1211.21 - PBDT36.8118.78 96 PBT30.0412.60 138 NP22.979.60 139 Powered by Capital Market - Live News

Venus Remedies will hold a meeting of the Board of Directors of the Company on 20 July 2026.

Venus Remedies announced that the 37th Annual General Meeting(AGM) of the company will be held on 20 August 2026.

Venus Remedies announced that the Board of Directors of the Company at its meeting held on 26 May 2026, inter alia, have recommended the final dividend of Rs 10 per equity Share (i.e. 100%) , subject to the approval of the shareholders.

Net profit of Venus Remedies rose 126.19% to Rs 47.50 crore in the quarter ended March 2026 as against Rs 21.00 crore during the previous quarter ended March 2025. Sales rose 33.05% to Rs 259.40 crore in the quarter ended March 2026 as against Rs 194.97 crore during the previous quarter ended March 2025.For the full year,net profit rose 126.81% to Rs 102.79 crore in the year ended March 2026 as against Rs 45.32 crore during the previous year ended March 2025. Sales rose 17.88% to Rs 769.60 crore in the year ended March 2026 as against Rs 652.89 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales259.40194.97 33 769.60652.89 18 OPM %24.4514.87 -19.1410.50 - PBDT68.3635.75 91 159.8284.42 89 PBT61.6131.04 98 134.1661.91 117 NP47.5021.00 126 102.7945.32 127 Powered by Capital Market - Live News